Please ensure Javascript is enabled for purposes of website accessibility
Home / News / St. Charles Business Record / Merck wins dismissal of Fosamax case set for trial

Merck wins dismissal of Fosamax case set for trial

Merck & Co. won dismissal of the second case scheduled for trial over claims its osteoporosis drug Fosamax caused so-called jaw death. U.S. District Judge John Keenan in Manhattan ruled in Merck's favor in an opinion Monday. Keenan said that experts for Bessie Flemings, a Mississippi resident, can't establish that Fosamax caused her osteonecrosis of the ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*